These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34013494)

  • 1. More evidence on TRIO missense mutations in the spectrin repeat domain causing severe developmental delay and recognizable facial dysmorphism with macrocephaly.
    Kloth K; Graul-Neumann L; Hermann K; Johannsen J; Bierhals T; Kortüm F
    Neurogenetics; 2021 Jul; 22(3):221-224. PubMed ID: 34013494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite Modulation of RAC1 by Mutations in TRIO Is Associated with Distinct, Domain-Specific Neurodevelopmental Disorders.
    Barbosa S; Greville-Heygate S; Bonnet M; Godwin A; Fagotto-Kaufmann C; Kajava AV; Laouteouet D; Mawby R; Wai HA; Dingemans AJM; Hehir-Kwa J; Willems M; Capri Y; Mehta SG; Cox H; Goudie D; Vansenne F; Turnpenny P; Vincent M; Cogné B; Lesca G; Hertecant J; Rodriguez D; Keren B; Burglen L; Gérard M; Putoux A; ; Cantagrel V; Siquier-Pernet K; Rio M; Banka S; Sarkar A; Steeves M; Parker M; Clement E; Moutton S; Tran Mau-Them F; Piton A; de Vries BBA; Guille M; Debant A; Schmidt S; Baralle D
    Am J Hum Genet; 2020 Mar; 106(3):338-355. PubMed ID: 32109419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel loss-of-function variants in TRIO are associated with neurodevelopmental disorder: case report.
    Schultz-Rogers L; Muthusamy K; Pinto E Vairo F; Klee EW; Lanpher B
    BMC Med Genet; 2020 Nov; 21(1):219. PubMed ID: 33167890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA analysis and computer-aided facial phenotyping help to classify a novel TRIO splice site variant.
    Schwartzmann S; Zhao M; Sczakiel HL; Hildebrand G; Ehmke N; Horn D; Mensah MA; Boschann F
    Am J Med Genet A; 2024 Jul; 194(7):e63599. PubMed ID: 38517182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental disease-associated de novo mutations and rare sequence variants affect TRIO GDP/GTP exchange factor activity.
    Katrancha SM; Wu Y; Zhu M; Eipper BA; Koleske AJ; Mains RE
    Hum Mol Genet; 2017 Dec; 26(23):4728-4740. PubMed ID: 28973398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations specific to the Rac-GEF domain of
    Pengelly RJ; Greville-Heygate S; Schmidt S; Seaby EG; Jabalameli MR; Mehta SG; Parker MJ; Goudie D; Fagotto-Kaufmann C; Mercer C; ; Debant A; Ennis S; Baralle D
    J Med Genet; 2016 Nov; 53(11):735-742. PubMed ID: 27418539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extending the phenotypes associated with TRIO gene variants in a cohort of 25 patients and review of the literature.
    Gazdagh G; Hunt D; Gonzalez AMC; Rodriguez MP; Chaudhry A; Madruga M; Vansenne F; Shears D; Curie A; Stattin EL; Anderlid BM; Trajkova S; Angelovska ES; McWilliam C; Wyatt PR; O'Driscoll M; Atton G; Bergman AK; Zacher P; Mewasingh LD; López AG; Alonso-Luengo O; Wai HA; Rohde O; Boiroux P; Debant A; Schmidt S; Baralle D
    Am J Med Genet A; 2023 Jul; 191(7):1722-1740. PubMed ID: 36987741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoinhibition of the GEF activity of cytoskeletal regulatory protein Trio is disrupted in neurodevelopmental disorder-related genetic variants.
    Bircher JE; Corcoran EE; Lam TT; Trnka MJ; Koleske AJ
    J Biol Chem; 2022 Sep; 298(9):102361. PubMed ID: 35963430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage-sensitive, reciprocal genetic interactions between the Abl tyrosine kinase and the putative GEF trio reveal trio's role in axon pathfinding.
    Liebl EC; Forsthoefel DJ; Franco LS; Sample SH; Hess JE; Cowger JA; Chandler MP; Shupert AM; Seeger MA
    Neuron; 2000 Apr; 26(1):107-18. PubMed ID: 10798396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrocephaly and developmental delay caused by missense variants in RAB5C.
    Koop K; Yuan W; Tessadori F; Rodriguez-Polanco WR; Grubbs J; Zhang B; Osmond M; Graham G; Sawyer S; Conboy E; Vetrini F; Treat K; Płoski R; Pienkowski VM; Kłosowska A; Fieg E; Krier J; Mallebranche C; Alban Z; Aldinger KA; Ritter D; Macnamara E; Sullivan B; Herriges J; Alaimo JT; Helbig C; Ellis CA; van Eyk C; Gecz J; Farrugia D; Osei-Owusu I; Adès L; van den Boogaard MJ; Fuchs S; Bakker J; Duran K; Dawson ZD; Lindsey A; Huang H; Baldridge D; Silverman GA; Grant BD; Raizen D; ; van Haaften G; Pak SC; Rehmann H; Schedl T; van Hasselt P
    Hum Mol Genet; 2023 Oct; 32(21):3063-3077. PubMed ID: 37552066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio.
    Sadybekov A; Tian C; Arnesano C; Katritch V; Herring BE
    Nat Commun; 2017 Sep; 8(1):601. PubMed ID: 28928363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Genotype-Phenotype Correlation in Children with KMT2E Gene-Related Neurodevelopmental Disorders: Report of Two New Cases and Review of Published Literature.
    Sharawat IK; Panda PK; Dawman L
    Neuropediatrics; 2021 Apr; 52(2):98-104. PubMed ID: 33111303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent KCNT2 missense variants affecting p.Arg190 result in a recognizable phenotype.
    Jackson A; Banka S; Stewart H; ; Robinson H; Lovell S; Clayton-Smith J
    Am J Med Genet A; 2021 Oct; 185(10):3083-3091. PubMed ID: 34061450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of autism spectrum disorder-related pathogenic trio variants by a novel structure-based approach.
    Rao S; Sadybekov A; DeWitt DC; Lipka J; Katritch V; Herring BE
    Mol Autism; 2024 Apr; 15(1):12. PubMed ID: 38566250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative trio mutant.
    Debreceni B; Gao Y; Guo F; Zhu K; Jia B; Zheng Y
    J Biol Chem; 2004 Jan; 279(5):3777-86. PubMed ID: 14597635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic TRIO variants associated with neurodevelopmental disorders perturb the molecular regulation of TRIO and axon pathfinding in vivo.
    Bonnet M; Roche F; Fagotto-Kaufmann C; Gazdagh G; Truong I; Comunale F; Barbosa S; Bonhomme M; Nafati N; Hunt D; Rodriguez MP; Chaudhry A; Shears D; Madruga M; Vansenne F; Curie A; Kajava AV; Baralle D; Fassier C; Debant A; Schmidt S
    Mol Psychiatry; 2023 Apr; 28(4):1527-1544. PubMed ID: 36717740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling human mutations to understand TRIO GEF function during development.
    Fingleton E; Roche KW
    Trends Neurosci; 2023 Jun; 46(6):411-412. PubMed ID: 36959051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple novel isoforms of Trio are expressed in the developing rat brain.
    McPherson CE; Eipper BA; Mains RE
    Gene; 2005 Feb; 347(1):125-35. PubMed ID: 15715966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo variants in PAK1 lead to intellectual disability with macrocephaly and seizures.
    Horn S; Au M; Basel-Salmon L; Bayrak-Toydemir P; Chapin A; Cohen L; Elting MW; Graham JM; Gonzaga-Jauregui C; Konen O; Holzer M; Lemke J; Miller CE; Rey LK; Wolf NI; Weiss MM; Waisfisz Q; Mirzaa GM; Wieczorek D; Sticht H; Abou Jamra R
    Brain; 2019 Nov; 142(11):3351-3359. PubMed ID: 31504246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous Missense Pathogenic Variants Within the Second Spectrin Repeat of SPTBN2 Lead to Infantile-Onset Cerebellar Ataxia.
    Accogli A; St-Onge J; Addour-Boudrahem N; Lafond-Lapalme J; Laporte AD; Rouleau GA; Rivière JB; Srour M
    J Child Neurol; 2020 Feb; 35(2):106-110. PubMed ID: 31617442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.